Disease · MONDO_0001577
Trials61
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 1 more is not shown, since the checks do not confirm it.
1 to 20 of 61
Download this page as JSON| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03656510 | Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection | Phase 2 | 246 | 2023-09-21 | Respiratory Syncytial Virus Infections | RILEMATOVIR | Its record names the disease | ClinicalTrials.gov |
| NCT02135614 | Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection | Phase 2 | 189 | 2018-05-11 | Respiratory Syncytial Virus Infection | PRESATOVIR | Its record names the disease | ClinicalTrials.gov |
| NCT02254408 | Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract | Phase 2 | 189 | 2018-08-06 | Respiratory Syncytial Virus | PRESATOVIR | Its record names the disease | ClinicalTrials.gov |
| NCT02979431 | Dose Ranging Study of ALX-0171 in Infants Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection | Phase 2 | 180 | 2019-10-18 | Respiratory Syncytial Virus Lower Respiratory Tract Infection | ALX-0171 | Open Targets' reading of its record | ClinicalTrials.gov |
| NCT03691623 | A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model | Phase 2 | 179 | 2022-05-03 | RSV Infection | ZELICAPAVIR | Its record names the disease | ClinicalTrials.gov |
| NCT00421304 | A Study to Evaluate a Single Intravenous Dose of Motavizumab for the Treatment of Children Hospitalized With Respiratory Syncytial Virus (RSV) Illness | Not applicable | 118 | 2021-08-27 | RSV Illness in ≤12 Months of Participants | MOTAVIZUMAB | Its record names the disease | ClinicalTrials.gov |
| NCT05559905 | Respiratory Syncytial Virus (RSV) Human Challenge Study of Molnupiravir in Healthy Participants (MK-4482-017) | Phase 2 | 116 | 2024-05-20 | Respiratory Syncytial Virus | MOLNUPIRAVIR | Its record names the disease | ClinicalTrials.gov |
| NCT04816721 | A Study to Evaluate EDP 938 Regimens in Children With RSV | Phase 2 | 99 | 2025-07-08 | Respiratory Syncytial Virus (RSV) | ZELICAPAVIR | Its record names the disease | ClinicalTrials.gov |
| NCT04196101 | A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult Subjects | Phase 2 | 82 | 2023-10-30 | Respiratory Syncytial Virus | ZELICAPAVIR | Its record names the disease | ClinicalTrials.gov |
| NCT03379675 | A Study to Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial Virus | Phase 2 | 72 | 2022-06-28 | Respiratory Syncytial Virus Infections | RILEMATOVIR | Its record names the disease | ClinicalTrials.gov |
| NCT02534350 | Presatovir in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) Infection | Phase 2 | 61 | 2018-11-28 | Respiratory Syncytial Virus (RSV) | PRESATOVIR | Its record names the disease | ClinicalTrials.gov |
| NCT02254421 | Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract | Phase 2 | 60 | 2018-05-11 | Respiratory Syncytial Virus Infection | PRESATOVIR | Its record names the disease | ClinicalTrials.gov |
| NCT00435994 | Assessment of Airway Obstruction in Infants With Lower Respiratory Infections | Not applicable | 59 | 2016-06-01 | Bronchiolitis, Respiratory Syncytial Virus Infections | EPINEPHRINE | Its record names the disease | ClinicalTrials.gov |
| NCT04225897 | A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection. | Phase 2 | 51 | 2024-10-23 | Respiratory Syncytial Virus (RSV), Lower Resp Tract Infection | SISUNATOVIR | Its record names the disease | ClinicalTrials.gov |
| NCT02935673 | Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine Regimens in Adult Participants Hospitalized With Respiratory Syncytial Virus | Phase 2 | 49 | 2019-12-24 | Respiratory Syncytial Viruses | LUMICITABINE | Its record names the disease | ClinicalTrials.gov |
| NCT02707523 | Prospective Pilot Clinical Trial of Azithromycin Treatment In Respiratory Syncytial Virus (RSV)- Induced Respiratory Failure In Children | Phase 2 | 48 | 2020-05-27 | Respiratory Syncytial Virus | AZITHROMYCIN | Its record names the disease | ClinicalTrials.gov |
| NCT00192504 | Safety Study of a Monoclonal Antibody to Respiratory Syncytial Virus (RSV) in Children Hospitalized With RSV Infection | Phase 1 | 31 | 2021-10-08 | Respiratory Syncytial Virus Prophylaxis | MOTAVIZUMAB | Its record names the disease | ClinicalTrials.gov |
| NCT04583280 | A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV) | Phase 3 | 28 | 2023-04-10 | Respiratory Tract Infections | RILEMATOVIR | Its record names the disease | ClinicalTrials.gov |
| NCT04068792 | A Two-Part Infant Study for Early Diagnosis of Respiratory Syncytial Virus (RSV) and Evaluation of JNJ-53718678 in RSV Acute Respiratory Tract Disease | Phase 2 | 22 | 2022-06-08 | Respiratory Syncytial Viruses | RILEMATOVIR | Its record names the disease | ClinicalTrials.gov |
| NCT04933968 | Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant | Phase 1/2 | 17 | 2024-06-06 | Respiratory Tract Viral Infections, Human Metapneumovirus (hMPV) Infection, Parainfluenza (PIV) Infection, Respiratory Syncytial Viral (RSV) Infection, Influenza Infection | SPUNOLEUCEL | Its record names the disease | ClinicalTrials.gov |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0001577/trials